[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Instituto Neurociencia Del Dolor\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":75},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100644668","ai-and-computer-vision-assisted-telerehabilitation-in-fibromyalgia-the-fibroia-20-trial-100644668",false,"NCT07674485","AI and Computer Vision-Assisted Telerehabilitation in Fibromyalgia: The FibroIA 2.0 Trial","Effectiveness of Artificial Intelligence- and Computer Vision-Assisted Telerehabilitation, With and Without Resistance Training, on Disease Impact and Physical Function in People With Fibromyalgia: A Randomized Controlled Trial (FibroIA 2.0)","fibroIA 2","Inclusion Criteria:\n\n* Adults aged 18 years or older, of any sex\u002Fgender, with a documented medical diagnosis of fibromyalgia established in primary or secondary healthcare settings according to the American College of Rheumatology (ACR) criteria (Häuser \\& Fitzcharles, 2018).\n* Individuals able to understand and complete the self-report questionnaires used in the study.\n* Individuals with access to a compatible electronic device (smartphone, tablet, or computer) and an internet connection required for participation in the telerehabilitation intervention.\n* Individuals with basic digital literacy skills, defined as the ability to use electronic devices and interact with commonly used applications.\n* Individuals who provide written informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Current participation in another structured therapeutic exercise program, whether supervised or unsupervised.\n* Moderate to severe functional dependence in activities of daily living, defined as a score \\\u003C60 on the Barthel Index.\n* Absolute contraindications to therapeutic exercise, including hypertensive crisis (≥170\u002F110 mmHg), dyspnea at rest, resting tachycardia, or severe glycemic abnormalities (blood glucose \\>250 mg\u002FdL or \\\u003C90 mg\u002FdL in individuals receiving insulin therapy).\n* Severe uncontrolled pain, defined as a score ≥8 on the Numeric Pain Rating Scale (NPRS) at rest.\n* Medical or neurological conditions that significantly limit the safe performance of physical exercise, as determined by clinical assessment.\n* Recent changes in fibromyalgia-specific pharmacological treatment within the previous 4 weeks, to ensure clinical stability throughout the intervention period.","ALL","18 Years",{"count":20,"type":21},66,"ESTIMATED","INTERVENTIONAL",[24],"NA","Fibromyalgia (FM) is a primary chronic pain condition with an estimated prevalence of 3.3% in Chile. It is characterized by widespread musculoskeletal pain, fatigue, and impaired physical function. Although exercise therapy is considered the first-line intervention, barriers to access and poor adherence limit its effectiveness within the public healthcare system. This study evaluates the effectiveness of an Artificial Intelligence (AI)- and Computer Vision (CV)-assisted telerehabilitation platform called Rehbody. The aim is to determine whether real-time technology-driven feedback can overcome the limitations of traditional face-to-face rehabilitation models by improving disease impact and functional capacity in Chilean patients with fibromyalgia.",[27,28,29],"Fibromyalgia","Fibromyalgia (FM)","Fibromyalgia Syndrome",[31,32,33,34],"fibromyalgia","exercise","telehealth","artificial intelligence","NOT_YET_RECRUITING","2026-06-28",{"date":38,"type":39},"2026-07-01","ACTUAL",{"date":41,"type":21},"2027-01-04",{"date":43,"type":21},"2027-06-21",{"name":45,"class":46},"Instituto Neurociencia Del Dolor","OTHER",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":5},"100567763","effectiveness-of-ai-guided-exercise-and-pain-neuroscience-education-for-fibromyalgia-fibroia-100567763","NCT06672419","Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)","Effectiveness of Tele-Rehabilitation for Fibromyalgia Using AI-Guided Exercise and Computer Vision Combined With Pain Neuroscience Education (FIBRO IA): A Randomized Controlled Trial","FibroIA","Inclusion Criteria:\n\n* Clinical diagnosis of fibromyalgia according to the American College of Rheumatology criteria (2016).\n* Age between 18 and 65 years.\n* Access to an internet-connected device (smartphone or computer).\n* Ability to participate in a tele-rehabilitation program.\n\nExclusion Criteria:\n\n* Participation in another clinical trial in the last 3 months.\n* Pregnancy or breastfeeding.\n* Uncontrolled severe medical conditions that could interfere with the intervention (e.g., cardiac or pulmonary diseases).\n* Physical or cognitive impairments that prevent following the exercise program.","65 Years",{"count":57,"type":21},50,[24],"This randomized controlled trial will evaluate the effectiveness of a 12-week, home-based telerehabilitation program for adults with fibromyalgia (FM) combining AI-guided exercise with Pain Neuroscience Education (PNE). Fifty participants will be randomized (1:1) to the digital intervention or usual care. The primary outcome is change in pain intensity from baseline to post-intervention (week 13 ± 7 days), with secondary outcomes including physical function and health-related quality of life. Outcome assessors, the principal investigator, and the study statistician will be blinded to group allocation until database lock.",[27,29],[27,62,63,64,65,66],"Tele-rehabilitation","Artificial Intelligence","Computer Vision","Pain Neuroscience Education","Randomized Controlled Trial","2025-12-27",{"date":69,"type":39},"2026-01-02",{"date":71,"type":21},"2026-02-01",{"date":73,"type":21},"2026-08-01",{"name":45,"class":46},""]